1. Home
  2. WAY vs IOVA Comparison

WAY vs IOVA Comparison

Compare WAY & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAY
  • IOVA
  • Stock Information
  • Founded
  • WAY 1999
  • IOVA 2007
  • Country
  • WAY United States
  • IOVA United States
  • Employees
  • WAY N/A
  • IOVA N/A
  • Industry
  • WAY
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WAY
  • IOVA Health Care
  • Exchange
  • WAY Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • WAY 5.3B
  • IOVA 2.6B
  • IPO Year
  • WAY 2024
  • IOVA N/A
  • Fundamental
  • Price
  • WAY $37.36
  • IOVA $5.89
  • Analyst Decision
  • WAY Strong Buy
  • IOVA Strong Buy
  • Analyst Count
  • WAY 10
  • IOVA 9
  • Target Price
  • WAY $35.67
  • IOVA $23.33
  • AVG Volume (30 Days)
  • WAY 1.2M
  • IOVA 8.2M
  • Earning Date
  • WAY 02-10-2025
  • IOVA 02-26-2025
  • Dividend Yield
  • WAY N/A
  • IOVA N/A
  • EPS Growth
  • WAY N/A
  • IOVA N/A
  • EPS
  • WAY N/A
  • IOVA N/A
  • Revenue
  • WAY $906,142,000.00
  • IOVA $90,858,000.00
  • Revenue This Year
  • WAY $18.97
  • IOVA $13,758.71
  • Revenue Next Year
  • WAY $7.54
  • IOVA $171.20
  • P/E Ratio
  • WAY N/A
  • IOVA N/A
  • Revenue Growth
  • WAY 18.23
  • IOVA 12751.20
  • 52 Week Low
  • WAY $20.26
  • IOVA $5.77
  • 52 Week High
  • WAY $38.35
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • WAY N/A
  • IOVA 26.25
  • Support Level
  • WAY N/A
  • IOVA $5.77
  • Resistance Level
  • WAY N/A
  • IOVA $8.15
  • Average True Range (ATR)
  • WAY 0.00
  • IOVA 0.44
  • MACD
  • WAY 0.00
  • IOVA -0.11
  • Stochastic Oscillator
  • WAY 0.00
  • IOVA 5.04

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in better transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for our solutions extends throughout the United States and includes Puerto Rico and other US Territories.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: